Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1041

1.

Bone density in transfusion dependent thalassemia patients in Urmia, Iran.

Valizadeh N, Farrokhi F, Alinejad V, Said Mardani S, Valizadeh N, Hejazi S, Noroozi M.

Iran J Ped Hematol Oncol. 2014;4(2):68-71. Epub 2014 Apr 20.

PMID:
25002928
[PubMed]
Free PMC Article
2.

MRI monitoring of myocardial iron overload: Use of cardiac MRI combined with hepatic MRI in a cohort of multi-transfused patients with thalassaemia.

Quatre A, Jacquier A, Petit P, Giorgi R, Thuret I.

Diagn Interv Imaging. 2014 Jul 4. pii: S2211-5684(14)00008-4. doi: 10.1016/j.diii.2014.01.007. [Epub ahead of print]

PMID:
25001363
[PubMed - as supplied by publisher]
3.

T2 MRI changes in the heart and liver of ex-thalassemic patients after hematopoietic stem cell transplantation.

Hamidieh AA, Tayebi S, Moeininia F, Shamshiri AR, Behfar M, Alimoghaddam K, Ghavamzadeh A.

Hematol Oncol Stem Cell Ther. 2014 Jul 3. pii: S1658-3876(14)00049-1. doi: 10.1016/j.hemonc.2014.06.002. [Epub ahead of print]

PMID:
24998835
[PubMed - as supplied by publisher]
Free Article
4.

Accuracy of Magnetic Resonance Imaging in Diagnosis of Liver Iron Overload: a Systematic Review and Meta-analysis.

Sarigianni M, Liakos A, Vlachaki E, Paschos P, Athanasiadou E, Montori VM, Murad MH, Tsapas A.

Clin Gastroenterol Hepatol. 2014 Jun 30. pii: S1542-3565(14)00928-8. doi: 10.1016/j.cgh.2014.05.027. [Epub ahead of print]

PMID:
24993364
[PubMed - as supplied by publisher]
5.

Vascular Dysfunction in Patients With Young β-Thalassemia: Relation to Cardiovascular Complications and Subclinical Atherosclerosis.

Adly AA, El-Sherif NH, Ismail EA, El-Zaher YA, Farouk A, El-Refaey AM, Wahba MS.

Clin Appl Thromb Hemost. 2014 Jul 2. pii: 1076029614541515. [Epub ahead of print]

PMID:
24989711
[PubMed - as supplied by publisher]
6.

Glucose homeostasis in Egyptian children and adolescents with β-Thalassemia major: Relationship to oxidative stress.

Metwalley KA, El-Saied AR.

Indian J Endocrinol Metab. 2014 May;18(3):333-9. doi: 10.4103/2230-8210.131169.

PMID:
24944927
[PubMed]
Free PMC Article
7.

A Significant Proportion of Thalassemia Major Patients Have Adrenal Insufficiency Detectable on Provocative Testing.

Huang KE, Mittelman SD, Coates TD, Geffner ME, Wood JC.

J Pediatr Hematol Oncol. 2014 Jun 17. [Epub ahead of print]

PMID:
24942024
[PubMed - as supplied by publisher]
8.

Impact of iron overload and potential benefit from iron chelation in low-risk myelodysplastic syndrome.

Shenoy N, Vallumsetla N, Rachmilewitz E, Verma A, Ginzburg Y.

Blood. 2014 Jun 12. pii: blood-2014-03-563221. [Epub ahead of print]

PMID:
24923296
[PubMed - as supplied by publisher]
9.

Deferasirox: a review of its use for chronic iron overload in patients with non-transfusion-dependent thalassaemia.

Shirley M, Plosker GL.

Drugs. 2014 Jun;74(9):1017-27. doi: 10.1007/s40265-014-0238-0.

PMID:
24919862
[PubMed - in process]
10.

Cost-utility of chelators in transfusion-dependent β-thalassemia major patients: a review of the pharmacoeconomic literature.

Lee TA, von Riedemann S, Tricta F.

Expert Rev Pharmacoecon Outcomes Res. 2014 Jun 11:1-10. [Epub ahead of print]

PMID:
24918168
[PubMed - as supplied by publisher]
11.

Iron distribution and histopathological characterization of the liver and heart of β-thalassemic mice with parenteral iron overload: Effects of deferoxamine and deferiprone.

Yatmark P, Morales NP, Chaisri U, Wichaiyo S, Hemstapat W, Srichairatanakool S, Svasti S, Fucharoen S.

Exp Toxicol Pathol. 2014 Sep;66(7):333-43. doi: 10.1016/j.etp.2014.03.002. Epub 2014 Jun 3.

PMID:
24907196
[PubMed - in process]
12.

Percutaneous excretion of iron and ferritin (through Al-hijamah) as a novel treatment for iron overload in beta-thalassemia major, hemochromatosis and sideroblastic anemia.

El Sayed SM, Abou-Taleb A, Mahmoud HS, Baghdadi H, Maria RA, Ahmed NS, Nabo MM.

Med Hypotheses. 2014 Aug;83(2):238-46. doi: 10.1016/j.mehy.2014.04.001. Epub 2014 Apr 8.

PMID:
24857772
[PubMed - in process]
13.

Combination of deferasirox and deferoxamine in clinical practice: An alternative scheme of chelation in thalassemia major patients.

Cassinerio E, Orofino N, Roghi A, Duca L, Poggiali E, Fraquelli M, Zanaboni L, Cappellini MD.

Blood Cells Mol Dis. 2014 May 17. pii: S1079-9796(14)00034-5. doi: 10.1016/j.bcmd.2014.04.006. [Epub ahead of print]

PMID:
24846580
[PubMed - as supplied by publisher]
14.

Longitudinal Study on Liver Functions in Patients with Thalassemia Major before and after Deferasirox (DFX) Therapy.

Soliman A, Yassin M, Al Yafei F, Al-Naimi L, Almarri N, Sabt A, De Sanctis V.

Mediterr J Hematol Infect Dis. 2014 Apr 7;6(1):e2014025. doi: 10.4084/MJHID.2014.025. eCollection 2014.

PMID:
24803998
[PubMed]
Free PMC Article
15.

Secondary haemochromatosis in a patient with thalassemia intermedia.

Rotaru I, Gaman A, Gaman G.

Curr Health Sci J. 2014 Jan;40(1):67-70. doi: 10.12865/CHSJ.40.01.13. Epub 2013 Dec 29.

PMID:
24791210
[PubMed]
Free PMC Article
16.

Iron overload in Beta thalassaemia major and intermedia patients.

Mishra AK, Tiwari A.

Maedica (Buchar). 2013 Sep;8(4):328-32.

PMID:
24790662
[PubMed]
Free PMC Article
17.

Efficacy and safety of combined oral iron chelation therapy with deferasirox and deferiprone in a patient with beta-thalassemia major and persistent iron overload.

Alavi S, Sadeghi E, Ashenagar A.

Blood Res. 2014 Mar;49(1):72-3. doi: 10.5045/br.2014.49.1.72. Epub 2014 Mar 24. No abstract available.

PMID:
24724073
[PubMed]
Free PMC Article
18.

β -thalassemia intermedia in Northern Iraq: a single center experience.

Al-Allawi NA, Jalal SD, Mohammad AM, Omer SQ, Markous RS.

Biomed Res Int. 2014;2014:262853. doi: 10.1155/2014/262853. Epub 2014 Feb 27.

PMID:
24719849
[PubMed - in process]
Free PMC Article
19.

Cardiac T2* MRI assessment in patients with thalassaemia major and its effect on the preference of chelation therapy.

Akcay A, Salcioglu Z, Oztarhan K, Tugcu D, Aydogan G, Ayaz NA, Bornaun H, Sen HS, Akici F, Akdana B.

Int J Hematol. 2014 Jun;99(6):706-13. doi: 10.1007/s12185-014-1575-1. Epub 2014 Apr 10.

PMID:
24719246
[PubMed - in process]
20.

Relationship among chelator adherence, change in chelators, and quality of life in Thalassemia.

Trachtenberg FL, Gerstenberger E, Xu Y, Mednick L, Sobota A, Ware H, Thompson AA, Neufeld EJ, Yamashita R.

Qual Life Res. 2014 Mar 30. [Epub ahead of print]

PMID:
24682717
[PubMed - as supplied by publisher]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk